Organogenesis Holdings

Organogenesis Holdings

World Rank (Jan-05-2024)
12,742
Market Cap (Jan-05-2024)
0.490 Billion USD
World Rank (Jul-30-2023)
12,042
Market Cap (Jul-30-2023)
0.560 Billion USD
World Rank (Jan-07-2022)
9,086
Market Cap (Jan-07-2022)
1.057 Billion USD
World Rank (Jan-01-2021)
8,103
Market Cap (Jan-01-2021)
0.962 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
ORGO
Market Cap (Mar-08-2026)
0.36
Employee Count
950
Employee Count as of Date
As on 2021
Headquarters City/State
Massachusetts
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
450 Million USD
Annual Operating Income in USD
22 Million USD
Annual Net Income in USD
16 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Total Assets in USD
449 Million USD
Total Liabilities in USD
183 Million USD
Total Equity in USD
265 Million USD
Balance Sheet for Period Ending
Dec-2022 ending year
Business Sector
Healthcare
Pharmaceutical
Company Website
ORGANOGENESIS HOLDINGS
Yahoo
Yahoo @ Nasdaq
Company Profile
Organogenesis Holdings is a Regenerative Medicine company focused on empowering healing through the development, manufacturing and sale of products for the advanced wound care and surgical and sports medicine markets. The headquarters is in USA.
Facts About Company
Organogenesis Holdings company annual revenue was 450 million USD and annual net income was 15 million USD as on Dec-2022.
Founded Year
1985
IPO Year
2016
Stock Exchange
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share